Partner with Linear Clinical Research

Linear is forging new ways in the delivery of high-quality Australian clinical trials, collaborating with global clinical trial sponsors and medical research partners to advance scientific innovation.

Why Sponsors Choose Linear

With Linear's multi-site, multi-phase capabilities, expedited participant enrolment, and extensive network of subject matter experts, sponsors can confidently deliver world-class results.

Linear’s dedicated team supports every stage of research from early feasibility to post-trial analysis providing complete clinical trial support for both domestic and international clinical trial partners. Our expertise includes:

  • Strategic project planning and protocol development for Phase I–IV studies


  • Australia’s first licensed private hospital dedicated to next-generation trials – the Advanced Clinical Trials Centre (ACTC)


  • Expedited recruitment through digital systems and investigator networks


  • Advanced nursing and care services prioritising patient welfare
    

  • Full-service facilities including pharmacy, labs, and real-time data quality control

Perth, Western Australia – Our hub for clinical trials offers the perfect blend of academic excellence, world-class healthcare infrastructure, and a thriving research community. With over 2.6 million residents and employing over 40,000 health professionals, Perth is emerging as a major medical research destination, providing our clients with unparalleled access to cutting-edge facilities and expertise.

How might you benefit?

Australia offers one of the most efficient regulatory environments for clinical trial collaboration with TGA oversight, competitive R&D tax incentives, and cost-effective operational models.

Why Choose Linear?

Linear is at the forefront of clinical research innovation in Australia, delivering excellence in every aspect of the trial process.

Speed

Our optimised model streamlines approvals, participant recruitment, and database lock, ensuring faster start-up and completion times for your Australian clinical trials.

Quality

We maintain the highest standards of GCP, regulatory compliance, and data integrity, giving sponsors confidence in every result.

Reliability

With over 450+ studies and 75% Phase I trials, Linear’s track record demonstrates proven consistency, 24/7 medical oversight, and commitment to participant safety.

Move at Speed with Linear’s Tech-Driven Research Capabilities

Linear is at the forefront of clinical research innovation in Australia, delivering excellence in every aspect of the trial process.

State-of-the-Art Technical Laboratory

Linear’s purpose-built laboratory supports advanced analytical techniques, including cell-based assays, cytometry (FACS ARIA II), and PBMC processing, enabling comprehensive clinical research partnerships.

Special Clinical Procedures

Through partnerships with diagnostic and imaging providers, we offer access to MRI, CT, PET, and other advanced procedures supporting full-service clinical trial collaboration.

Secure Data Handling and Transfer

We uphold the highest standards of Data Integrity, Regulatory Compliance, and Good Clinical Practice to guarantee reliability and transparency for each clinical trial sponsor.

Seamless Concept-to-Delivery Solutions

From trial planning to quality assurance, Linear’s integrated model delivers efficiency, accuracy, and compliance through every stage of your study.

Clinical Trial Performance

Your Clinical Trial Journey

Step 1.

Contact Our Team

Our experienced staff will review your research goals and discuss how Linear can help transition your project from concept to clinical reality.

Step 2.

Get Started with Just a Few Details

We’ll work closely with you to develop a preliminary proposal, protocol synopsis, and milestones for trial initiation.

Step 3.

Protocol Design & Rapid Start-Up

Linear’s streamlined ethics and site setup processes ensure swift activation and compliance with all Australian standards.

Step 4.

Discover the Benefits

Enjoy seamless communication, robust project management, and measurable success throughout your partnership.

We Facilitate Every Stage of the Clinical Research and Medical Innovation Journey

Linear adds value at every point of the clinical research pathway from design to delivery, combining scientific expertise with operational excellence.

We were thoroughly impressed with the world class service; the execution of the trial was excellent, the project was completed ahead of schedule.

Professor Daria Mochley-Rosen

SPARK at Stanford

We have worked closely with Linear and leading cardiometabolic expert, Professor Gerald Watts across multiple programs spanning phase I to III. The expertise of Professor Watts, Linear’s world class facilities, and the favourable regulatory environment in Australia have helped advance these important programs to where they are today.

Dr. James Hamilton

Arrowhead Pharmaceuticals

Talk with us

Partner with a life-science organisation at the forefront of clinical trials.

Latest News

Stay informed with updates from Linear Clinical Research, including insights into Australian clinical trials, medical innovations, and stories from our research community.

04 November, 2025

Before you attend your screening appointment

04 November, 2025

Thank you for your interest

04 November, 2025

Thank You Awesome work!

Frequently asked questions

Why is Australia a preferred destination for clinical trials?

Australia offers fast regulatory approvals (CTN), no IND requirement for early-phase trials, high-quality data, and generous R&D tax incentives (up to 43.5%).

Yes, data is highly regarded and accepted by agencies like the U.S. FDA, as Australian trials adhere to ICH-GCP guidelines.

It offers eligible sponsors a refundable tax offset of up to 43.5% of R&D expenditure, reducing the financial burden of trials.

Submit documentation to the TGA via an online portal after HREC ethical approval. TGA acknowledgment typically occurs within days.

Yes. Many sponsors initiate First-in-Human (FIH) trials in Australia while preparing their US IND, saving time.

Why is Australia a preferred destination for clinical trials?

Australia offers fast regulatory approvals (CTN), no IND requirement for early-phase trials, high-quality data, and generous R&D tax incentives (up to 43.5%).

Yes, data is highly regarded and accepted by agencies like the U.S. FDA, as Australian trials adhere to ICH-GCP guidelines.

It offers eligible sponsors a refundable tax offset of up to 43.5% of R&D expenditure, reducing the financial burden of trials.

Submit documentation to the TGA via an online portal after HREC ethical approval. TGA acknowledgment typically occurs within days.

Yes. Many sponsors initiate First-in-Human (FIH) trials in Australia while preparing their US IND, saving time.

Linear offers proven expertise (especially oncology), over 500 trials delivered (75% early-phase), integrated lab capabilities, and high recruitment rates

Deep expertise in Oncology (solid/hematologic), Rare diseases, Immunotherapy, and early-phase dose escalation/PK/PD studies.

(Answer to be placed in a table format in the sheet, listing task responsibilities for Linear vs. CRO).

Rich Note - Where is the table?

Yes. We manage logistics, including temperature-controlled packaging, customs, and international compliance, to maintain sample integrity.

Yes. Linear can serve as your Australian legal sponsor under the CTN scheme.

Become a Sponsor Today